Journal Information
Vol. 94. Issue 4.
Pages 340-341 (July - August 2018)
Vol. 94. Issue 4.
Pages 340-341 (July - August 2018)
Editorial
Open Access
Post-infectious bronchiolitis obliterans in children: is general quality of life the right measure?
Bronquiolite obliterante pós-infecciosa em crianças: a qualidade de vida geral é a medida certa?
Visits
3017
David Gozal
University of Chicago, Biological Sciences Division, Pritzker School of Medicine, Department of Pediatrics, Sections of Pediatric Pulmonology and Sleep Medicine, Chicago, United States
Related content
J Pediatr (Rio J). 2018;94:374-910.1016/j.jped.2017.07.021
Edgar E. Sarria, Eduardo Mundstock, Denise G. Machado, Helena T. Mocelin, Gilberto B. Fischer, Silvana P. Furlan, Ivan C.F. Antonello, Ricardo Stein, Rita Mattiello
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

In recent years, the long-term survival of many chronic progressive pulmonary diseases has improved; with such progress, the attention has also shifted from strictly focusing on physiological measurements of lung function and other physical characteristics to incorporating quality of life (QOL) assessments, with the latter reflecting a degree of interdependency with the severity of the respiratory condition. For example, in patients with cystic fibrosis (CF), factors such as body mass index, a correlate of nutritional status, and FEV1, a reporter of overall expiratory flow limitation and bronchial involvement, have emerged as important factors contributing to QOL.1 Similarly, the frequency of hospital admissions for pulmonary exacerbations, sleep quality, adherence, depression, and physical activity measures are also major contributors to QOL ratings in CF.2–7 As a corollary, reduced QOL is reported by children with non-CF bronchiectatic diseases8 and disease-specific QOL tools have been developed for assessing asthmatic children,9–11 further reinforcing the importance of a comprehensive evaluation that attests to integrative functioning in the context of chronic illness, while also potentially serving as an objective follow-up and longitudinal monitoring instrument.12 In this context, Sarria et al. now report their QOL findings among 34 children suffering from post-infectious bronchiolitis obliterans (PIBO) compared to 34 controls.13 PIBO is a frequently irreversible obstructive lung disease characterized by sub-epithelial inflammation and fibrotic narrowing of the smaller airways following a lower respiratory tract infection during early childhood. Despite its typical history and clinical examination, the diagnosis is characteristically confirmed by bioptic histopathological assessments along with pertinent radiological findings consisting of heterogeneous vascular perfusion alterations along with air trapping with or without bronchiectasis.14,15 Indeed, since lung function tests are either not feasible or require specialized settings in young children, implementation of such approaches for the diagnosis of PIBO is woefully inadequate at best.16–20 As would be anticipated from patients suffering from chronic obstructive respiratory symptoms that are likely to affect their capacity for physical activity, as well as other functions during day and night,21 the overall QOL was reduced in PIBO patients in both the health-related and school-related domains of the well-validated instrument that was used.22 Thus, the findings attest to the significant impact that this relatively rare, yet important diagnostic entity imposes on living conditions. Some limitations to this study deserve comment, to instigate future research. First, it would have been of interest to explore potential associations between available spirometric measurements and QOL measures, Secondly, the inclusion of a physical activity test such as the six-minute walk test (6-MWT) would be highly desirable, as would be the evaluation with overnight polysomnography (PSG); the potential independent contributions of 6-MWT performance and PSG findings to QOL could provide further insights as to the major determinants of QOL. Finally, and as raised by the investigators, future longitudinal periodic and concurrent assessments of clinical, radiological, functional, and QOL measures may shed some light as to the potentially important value of assessing QOL as a readily available, yet easy to obtain score that provides insights into disease severity, response to therapy, and prognostic tracking.

In summary and unsurprisingly, similar to many chronic respiratory diseases, PIBO adversely affects QOL in children. This interesting article should be a reminder to all of us pediatricians that the term “breath of life” is meaningful and should not be taken for granted.

Conflicts of interest

The author declares no conflicts of interest.

References
[1]
Habib A-RR, J. Manji, P.G. Wilcox, A.R. Javer, J.A. Buxton, B.S. Quon.
A systematic review of factors associated with health-related quality of life in adolescents and adults with cystic fibrosis.
Ann Am Thorac Soc, 12 (2015), pp. 420-428
[2]
H. Hebestreit, S. Kriemler, T. Radtke.
Exercise for all cystic fibrosis patients: is the evidence strengthening?.
Curr Opin Pulm Med, 21 (2015), pp. 591-595
[3]
C.T. Solem, M. Vera-Llonch, S. Liu, M. Botteman, B. Castiglione.
Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis.
Health Qual Life Outcomes, 14 (2016), pp. 63
[4]
K. Vandekerckhove, M. Keyzer, J. Cornette, I. Coomans, F. Pyl, F. De Baets, et al.
Exercise performance and quality of life in children with cystic fibrosis and mildly impaired lung function: relation with antibiotic treatments and hospitalization.
Eur J Pediatr, 176 (2017), pp. 1689-1696
[5]
M. Vandeleur, L.M. Walter, D.S. Armstrong, P. Robinson, G.M. Nixon, R.S. Horne.
Quality of life and mood in children with cystic fibrosis: associations with sleep quality.
J Cyst Fibros, (2017),
Dec 24.
[6]
M. van Horck, B. Winkens, G. Wesseling, K. de Winter-de Groot, I. de Vreede, Q. Jöbsis, et al.
Factors associated with changes in health-related quality of life in children with cystic fibrosis during 1-year follow-up.
Eur J Pediatr, 176 (2017), pp. 1047-1054
[7]
K.B. Knudsen, T. Pressler, L.H. Mortensen, M. Jarden, M. Skov, A.L. Quittner, et al.
Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis.
Springerplus, 5 (2016), pp. 1216
[8]
A.M. Nathan, J.A. de Bruyne, K.P. Eg, S. Thavagnanam.
Review: quality of life in children with non-cystic fibrosis bronchiectasis.
Front Pediatr, 5 (2017), pp. 84
[9]
C. Roncada, R. Mattiello, P.M. Pitrez, E.E. Sarria.
Specific instruments to assess quality of life in children and adolescents with asthma.
J Pediatr (Rio J), 89 (2013), pp. 217-225
[10]
R.S. Everhart, B.H. Fiese.
Asthma severity and child quality of life in pediatric asthma: a systematic review.
Patient Educ Couns, 75 (2009), pp. 162-168
[11]
C.F. Chiou, M.R. Weaver, M.A. Bell, T.A. Lee, J.W. Krieger.
Development of the multi-attribute Pediatric Asthma Health Outcome Measure (PAHOM).
Int J Qual Health Care, 17 (2005), pp. 23-30
[12]
E.F. Juniper.
How important is quality of life in pediatric asthma?.
Pediatr Pulmonol Suppl, 15 (1997), pp. 17-21
[13]
E.E. Sarria, E. Mundstock, D.G. Machado, H.T. Mocelin, G.B. Fischer, S.P. Furlan, et al.
Health-related quality of life in patients with bronchiolitis obliterans.
J Pediatr (Rio J), 94 (2018), pp. 374-379
[14]
L. Zhang, K. Irion, N. da Silva Porto, F. Abreu e Silva.
High-resolution computed tomography in pediatric patients with postinfectious bronchiolitis obliterans.
J Thorac Imaging, 14 (1999), pp. 85-89
[15]
R. Mattiello, E.E. Sarria, J. Mallol, G.B. Fischer, H. Mocelin, R. Bello, et al.
Post-infectious bronchiolitis obliterans: can CT scan findings at early age anticipate lung function?.
Pediatr Pulmonol, 45 (2010), pp. 315-319
[16]
A.J. Colom, A.M. Teper.
Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children.
Pediatr Pulmonol, 44 (2009), pp. 1065-1069
[17]
R.A. Mosquera, S.S. Hashmi, S.E. Pacheco, A. Reverdin, J. Chevallier, G.N. Colasurdo.
Dysanaptic growth of lung and airway in children with post-infectious bronchiolitis obliterans.
Clin Respir J, 8 (2014), pp. 63-71
[18]
S. Cazzato, V. Poletti, F. Bernardi, L. Loroni, L. Bertelli, S. Colonna, et al.
Airway inflammation and lung function decline in childhood post-infectious bronchiolitis obliterans.
Pediatr Pulmonol, 43 (2008), pp. 381-390
[19]
V. Aguerre, C. Castanos, H.G. Pena, M. Grenoville, P. Murtagh.
Postinfectious bronchiolitis obliterans in children: clinical and pulmonary function findings.
Pediatr Pulmonol, 45 (2010), pp. 1180-1185
[20]
E. Lee, J. Yoon, H.J. Cho, S.J. Hong, J. Yu.
Respiratory reactance in children aged three to five years with postinfectious bronchiolitis obliterans is higher than in those with asthma.
Acta Paediatr, 106 (2017), pp. 81-86
[21]
R. Mattiello, E.E. Sarria, R. Stein, G.B. Fischer, H.T. Mocelin, S.S. Barreto, et al.
Functional capacity assessment in children and adolescents with post-infectious bronchiolitis obliterans.
J Pediatr (Rio J), 84 (2008), pp. 337-343
[22]
D.A. Klatchoian, C.A. Len, M.T. Terreri, M. Silva, C. Itamoto, R.M. Ciconelli, et al.
Quality of life of children and adolescents from São Paulo: reliability and validity of the Brazilian version of the Pediatric Quality of Life Inventory TM version 4.0 Generic Core Scales.
J Pediatr (Rio J), 84 (2008), pp. 308-315

Please cite this article as: Gozal D. Post-infectious bronchiolitis obliterans in children: is general quality of life the right measure?. J Pediatr (Rio J). 2018;94:340–1.

See paper by Sarria et al. in pages 374–9.

Copyright © 2018. Sociedade Brasileira de Pediatria
Idiomas
Jornal de Pediatria (English Edition)
Article options
Tools
en pt
Taxa de publicaçao Publication fee
Os artigos submetidos a partir de 1º de setembro de 2018, que forem aceitos para publicação no Jornal de Pediatria, estarão sujeitos a uma taxa para que tenham sua publicação garantida. O artigo aceito somente será publicado após a comprovação do pagamento da taxa de publicação. Ao submeterem o manuscrito a este jornal, os autores concordam com esses termos. A submissão dos manuscritos continua gratuita. Para mais informações, contate assessoria@jped.com.br. Articles submitted as of September 1, 2018, which are accepted for publication in the Jornal de Pediatria, will be subject to a fee to have their publication guaranteed. The accepted article will only be published after proof of the publication fee payment. By submitting the manuscript to this journal, the authors agree to these terms. Manuscript submission remains free of charge. For more information, contact assessoria@jped.com.br.
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.